Demand for Monoclonal Antibody Treatment Surges Across the Country

Published on August 27, 2021

The demand for monoclonal antibody therapies to treat COVID-19 cases has risen dramatically in America in recent weeks as cases soar. Former President Donald Trump received an antibody cocktail manufactured by Regeneron Pharmaceuticals when he was infected with the virus,…

Read Full Article (External Site)